Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of M1/M2 Tumor Associated Macrophage (TAM) Polarization on Cancer Progression and Prognosis Prediction

NCT00690261 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT00690261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00690261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of M1/M2 Tumor Associated Macrophage (TAM) Polarization on Cancer Progression and Prognosis Prediction
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2007
Completion date
August 31, 2010
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, tumor